Segura, AG, Prohens, L, Julià, L, Amoretti, S, Ribero, M, Pino-Camacho, L, Cano-Escalera, G, Mane, A, Rodriguez-Jimenez, R, Roldan, A, Sarró, S, Ibañez, A, Usall, J, Lobo, A, Garcia-Rizo, C, Cuesta, MJ, Parellada, M, González-Pinto, A, Berrocoso, E, Mas, S, Rodriguez, N, Perez-Ramos, A, Salmeron, S, González-Peñas, J, Gurriarán, X, Farré, A, Pousa, E, Zorrilla, I, Mar-Barrutia, L, Trabsa, A, Martinez, L, Sánchez-Cabezudo, A, Jiménez-López, E, Pomarol-Clotet, E, Salvador, R, Butjosa, A, Elena, RA, Moreno-Izco, L, Torres, AMS, Saiz, J, León-Quismondo, L, Rivero, O, González-Blanco, L, De-la-Camára, C, Bernardo, M. Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 94DOI:10.1016/j.euroneuro.2025.02.003. PMID:39956014. IF:6.700(Q1/1D).

Forte, MF, Clougher, D, Segura, AG, Mezquida, G, Sánchez-Torres, AM, Vieta, E, Garriga, M, Lobo, A, González-Pinto, AM, Diaz-Caneja, CM, Roldan, A, Martínez-Arán, A, de la Serna, E, Mané, A, Mas, S, Torrent, C, Allot, K, Bernardo, M, Amoretti, S, PEPs Grp. From Genetics to Psychosocial Functioning: Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis. ACTA PSYCHIATRICA SCANDINAVICA. 2025; 151(5)DOI:10.1111/acps.13779. PMID:39722475. IF:5.000(Q1/2D).

Molero, P, Ibañez, A, de Diego-Adeliño, J, Ramos-Quiroga, JA, Dorado, MG, Rengel, PML, Saiz, PA. A Real-World Study on the Use, Effectiveness, and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression: INTEGRATE Study. ADVANCES IN THERAPY. 2025; 42(5)DOI:10.1007/s12325-025-03149-z. PMID:40106175. IF:4.000(Q1/3D).

Portella, M, Vicent-Gil, M, Vall, G, Legido, T, Mur, M, Guarch, J, de Diego-Adeliño, J, González-Simarro, S, Raventós, B, Vera, J, Gawron, L, Bonnin, CD, Clavé, N, Cámara-Gómez, RM, Kiskeri-Aiguabella, A, Romero-López, M, Rodríguez-Pérez, I, Carrasco, J, Alemany, C, Alvarez, NC. Integral Cognitive Remediation (INCREM) as a Strategy to Enhance Long-Term Psychosocial Recovery in Depression: A Multicentric Randomized Controlled Trial. BIOLOGICAL PSYCHIATRY. 2025; 97(9)DOI:. PMID:. IF:9.000(Q1/1D).

Porta-Casteràs, D, Cano, M, Alonso, P, Vicent-Gil, M, de la Peña-Arteaga, V, Miquel-Giner, N, Martínez-Zalacaín, I, Mar-Barrutia, L, López-Sola, M, Andrews-Hanna, JR, Soriano-Mas, C, Cardoner, N, López-Solà, C, Serra-Blasco, M. Mindfulness-Based Cognitive Therapy Neurobiology During Self-Referential Processing in Treatment-Resistant Obsessive-Compulsive Disorder. BIOLOGICAL PSYCHIATRY. 2025; 97(9)DOI:. PMID:. IF:9.000(Q1/1D).

Avila-Parcet, A, Martín-Blanco, A, Gawron, L, Cano, M, Peña-Arteaga, VD, Carceller-Sindreu, M, Soler, J, Portella, MJ, Faustino, G, Cardoner, N, Farrés, CCI. Evaluating the efficacy of radically open dialectical behavior therapy (RO-DBT) in patients with anorexia nervosa: study protocol for a randomized controlled clinical trial. BMC Psychiatry. 2025; 25(1)DOI:10.1186/s12888-025-06854-9. PMID:40251556. IF:3.600(Q1/3D).

Díaz-Cutraro, L, Verdaguer-Rodríguez, M, García-Mieres, H, Ferrer-Quintero, M, López-Carrilero, R, Palma-Sevillano, C, Lamarca, M, Espinosa, V, Barrigón, ML, González-Higueras, F, Pousa, E, Grasa, E, Lorente-Rovira, E, Gutiérrez-Zotes, A, Barajas, A, Ruiz-Delgado, I, Cid, J, Moritz, S, Rico, J, Sevilla-Llewellyn-Jones, J, Haro, JM, Ochoa, S. Sex-based differences in Jumping to Conclusions: a multidimensional analysis of first-episode psychosis. SCHIZOPHRENIA. 2025; 11(1)DOI:10.1038/s41537-025-00579-0. PMID:40221473. IF:4.100(Q1/2D).

Soler, J, Arqueros, M, Schmidt, C, Otero, D, Soria-Madrid, A, Campins, MJ, Catalan, A, Casellas, E, Espeso, R, Pascual, JC. Scale to measure dialectical thinking from dialectical behavior therapy perspective.. EUROPEAN JOURNAL OF PSYCHIATRY. 2025; 39(2)DOI:10.1016/j.ejpsy.2025.100305. PMID:. IF:1.500(Q3/7D).

Cañizares, S, Nuño, L, Barrio, P, Forner-Puntonet, M, Gavotti, C, Monràs, M, Gavín, P, Navinés, R, Flores, L, Barrios, M, Andreu, A, Molero, J, Jimenez, A, Vidal, J, Lligoña, A. Alcohol and Other Substance Screening in Bariatric Surgery Candidates: Utility of Self-Report and Toxicology Tests, Including Ethyl-Glucoronide. OBESITY SURGERY. 2025; 35(4)DOI:10.1007/s11695-025-07774-z. PMID:40072740. IF:3.100(Q1/2D).

Vicent-Gil, M, Trujols, J, Sagues, T, Serra-Blasco, M, Navarra-Ventura, G, Mantellini, CL, Crivillés, S, Portella, MJ, Cardoner, N. Insights on the cognitive enhancement effect of desvenlafaxine in major depressive disorder. Annals of General Psychiatry. 2025; 24(1)DOI:10.1186/s12991-025-00552-2. PMID:40108685. IF:3.100(Q2/4D).

Cardoner, N, Gutiérrez-Rojas, L, Saiz, P, Lahera, G, alvarez-Mon, MA, Ortega, PA, Pérez-Páramo, M. Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness. Frontiers in Pharmacology. 2025; 16DOI:10.3389/fphar.2025.1483770. PMID:39989902. IF:4.800(Q1/2D).

Nicolaou, S, Pascual, JC, Soler, J, Ortega, G, Marco-Pallarés, J, Vega, D. Mapping punishment avoidance learning deficits in non-suicidal self-injury in young adults with and without borderline personality disorder: An fMRI study. JOURNAL OF AFFECTIVE DISORDERS. 2025; 370DOI:10.1016/j.jad.2024.11.026. PMID:39542117. IF:4.900(Q1/2D).

Portella, MJ, Arteaga-Henríquez, G, de Diego-Adeliño, J, Trujols, J, Puigdemont, D, Pérez, J, Alemany, C, Carrasco-Hernández, J, Udina, M, Cardoner, N, Vicent-Gil, M. Linking cognitive function and biological markers in depression: Can IL-6 plasma levels and attention domain be used as an ensemble classification system?. GENERAL HOSPITAL PSYCHIATRY. 2025; 92DOI:10.1016/j.genhosppsych.2024.10.003. PMID:39395857. IF:3.700(Q1/3D).

Seppälä, J, Grasa, E, Alonso-Solis, A, Roldan-Bejarano, A, Haapea, M, Isohanni, M, Miettunen, J, Mendivelso, JC, Almazán, C, Rubinstein, K, Caspi, A, Unoka, Z, Farkas, K, Reixach, E, Berdun, J, Usall, J, Ochoa, S, Corripio, I, Jääskeläinen, E. Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study. Jmir Human Factors. 2025; 12DOI:10.2196/67659. PMID:40372941. IF:(Q/D).

Casanovas, F, Dinamarca, F, Posso, M, Mané, A, Oller, S, Córcoles, D, Macià, F, Sala, M, Pérez-Sola, V, Ruiz, AI. Cancer characteristics in patients with schizophrenia: a 25-year retrospective analysis. PSYCHIATRY RESEARCH. 2024; 342DOI:10.1016/j.psychres.2024.116206. PMID:39321636. IF:3.900(Q1/2D).

Núñez, C, Stephan-Otto, C, Roldán, A, Grasa, EM, Escartí, MJ, García-Iturrospe, EJA, García-Martí, G, de la Iglesia-vaya, M, Nacher, J, Portella, MJ, Corripio, I. Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024; 89DOI:10.1016/j.euroneuro.2024.09.006. PMID:39341083. IF:6.700(Q1/1D).

Kiebs, M, Farrar, DC, Yrondi, A, Cardoner, N, Tuovinen, N, Redlich, R, Dannlowski, U, Soriano-Mas, C, Dols, A, Takamiya, A, Tendolkar, I, Narr, KL, Espinoza, R, Laroy, M, van Eijndhoven, P, Verwijk, E, van Waarde, J, Verdijk, J, Maier, HB, Nordanskog, P, van Wingen, G, van Diermen, L, Emsell, L, Bouckaert, F, Repple, J, Camprodon, JA, Wade, BSC, Donaldson, KT, Oltedal, L, Kessler, U, Hammar, A, Sienaert, P, Hebbrecht, K, Urretavizcaya, M, Belge, JB, Argyelan, M, Baradits, M, Obbels, J, Draganski, B, Philipsen, A, Sartorius, A, Rhebergen, D, Ousdal, OT, Hurlemann, R, McClintock, S, Erhardt, EB, Abbott, CC. Electroconvulsive therapy and cognitive performance from the Global ECT MRI Research Collaboration. JOURNAL OF PSYCHIATRIC RESEARCH. 2024; 179DOI:10.1016/j.jpsychires.2024.09.013. PMID:39312853. IF:3.200(Q2/4D).

Jordà-Baleri, T, Garriga, M, Mezquida, G, Cuesta, MJ, Martinez-Aran, A, Garcia-Rizo, C, Lobo, A, González-Pinto, A, Diaz-Caneja, CM, Roldán, A, Vieta, E, Baeza, I, Trabsa, A, Montalvo, I, Tortorella, A, Menculini, G, Verdolini, N, Ramos-Quiroga, JA, Torres, AMS, Bernardo, M, Amoretti, S. Sex differences in prolactin levels and clinical outcomes in patients with a first psychotic episode. PSYCHONEUROENDOCRINOLOGY. 2024; 169DOI:10.1016/j.psyneuen.2024.107112. PMID:39106582. IF:3.600(Q1/3D).

Hogg, B, Radua, J, Gardoki-Souto, I, Fontana-McNally, M, Lupo, W, Reinares, M, Jimenez, E, Madre, M, Blanco-Presas, L, Cortizo, R, Massó-Rodriguez, A, Castaño, J, Argila, I, Castro-Rodriguez, JI, Comes, M, Macias, C, Sánchez-González, R, Mur-Mila, E, Novo, P, Rosa, AR, Vieta, E, Padberg, F, Pérez-Solà, V, Valiente-Gómez, A, Moreno-Alcázar, A, Amann, BL. EMDR therapy vs. supportive therapy as adjunctive treatment in trauma-exposed bipolar patients: A randomised controlled trial. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2024; 17(4)DOI:10.1016/j.sjpmh.2023.11.005. PMID:38061553. IF:2.800(Q2/4D).

Malan-Müller, S, Vidal, R, O'Shea, E, Montero, E, Figuero, E, Zorrilla, I, de Diego-Adeliño, J, Cano, M, García-Portilla, MP, González-Pinto, A, Leza, JC. Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes. Translational Psychiatry. 2024; 14(1)DOI:10.1038/s41398-024-03122-4. PMID:39368974. IF:6.200(Q1/1D).